Berkshire Hathaway Inc. (BMV:BRKB)
Mexico · Delayed Price · Currency is MXN 8,718.82
+75.53 (0.87%)
At close: Aug 5, 2025
Intercept Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 62,918 | 88,995 | 96,223 | -22,759 | 89,937 | 42,521 | Upgrade |
Depreciation & Amortization | 13,083 | 12,855 | 12,486 | 10,899 | 10,718 | 10,596 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 10,638 | Upgrade |
Loss (Gain) From Sale of Investments | -40,038 | -64,148 | -80,365 | 66,767 | -77,576 | -40,905 | Upgrade |
Other Operating Activities | 8,375 | -326 | 411 | -2,313 | -2,370 | 1,357 | Upgrade |
Change in Accounts Receivable | -2,463 | 626 | -1,949 | -5,621 | -5,864 | -1,609 | Upgrade |
Change in Inventory | 13 | 591 | 1,426 | -4,779 | -1,862 | 681 | Upgrade |
Change in Unearned Revenue | 153 | 376 | 1,854 | 1,861 | 2,306 | 1,587 | Upgrade |
Change in Income Taxes | -19,269 | -8,163 | 14,865 | -12,872 | 15,330 | 7,195 | Upgrade |
Change in Other Net Operating Assets | 4,640 | -214 | 4,245 | 6,167 | 8,808 | 7,712 | Upgrade |
Operating Cash Flow | 27,412 | 30,592 | 49,196 | 37,350 | 39,427 | 39,773 | Upgrade |
Operating Cash Flow Growth | -47.52% | -37.82% | 31.72% | -5.27% | -0.87% | 2.81% | Upgrade |
Capital Expenditures | -19,187 | -18,976 | -19,409 | -15,464 | -13,276 | -13,012 | Upgrade |
Cash Acquisitions | -396 | -396 | -8,604 | -10,594 | -456 | -2,532 | Upgrade |
Investment in Securities | 52,169 | 9,280 | -5,335 | -61,782 | 42,354 | -18,252 | Upgrade |
Other Investing Activities | 735 | -195 | 685 | 239 | 770 | -3,961 | Upgrade |
Investing Cash Flow | 33,321 | -10,287 | -32,663 | -87,601 | 29,392 | -37,757 | Upgrade |
Short-Term Debt Issued | - | - | 2,407 | - | - | - | Upgrade |
Long-Term Debt Issued | - | 13,186 | 7,817 | 12,695 | 6,920 | 14,370 | Upgrade |
Total Debt Issued | 9,740 | 13,186 | 10,224 | 12,695 | 6,920 | 14,370 | Upgrade |
Short-Term Debt Repaid | - | -3,059 | - | -596 | -624 | -1,118 | Upgrade |
Long-Term Debt Repaid | - | -11,947 | -11,311 | -3,928 | -7,048 | -6,461 | Upgrade |
Total Debt Repaid | -8,703 | -15,006 | -11,311 | -4,524 | -7,672 | -7,579 | Upgrade |
Net Debt Issued (Repaid) | 1,037 | -1,820 | -1,087 | 8,171 | -752 | 6,791 | Upgrade |
Repurchase of Common Stock | - | -2,918 | -9,171 | -7,854 | -27,061 | -24,706 | Upgrade |
Other Financing Activities | -3,562 | -5,622 | -4,147 | -1,979 | -695 | -429 | Upgrade |
Financing Cash Flow | -2,525 | -10,360 | -14,405 | -1,662 | -28,508 | -18,344 | Upgrade |
Foreign Exchange Rate Adjustments | -51 | -212 | 116 | -394 | -1 | 92 | Upgrade |
Net Cash Flow | 58,157 | 9,733 | 2,244 | -52,307 | 40,310 | -16,236 | Upgrade |
Free Cash Flow | 8,225 | 11,616 | 29,787 | 21,886 | 26,151 | 26,761 | Upgrade |
Free Cash Flow Growth | -74.53% | -61.00% | 36.10% | -16.31% | -2.28% | 17.85% | Upgrade |
Free Cash Flow Margin | 2.22% | 3.13% | 8.17% | 7.25% | 9.47% | 10.90% | Upgrade |
Free Cash Flow Per Share | 5720.58 | 8079.46 | 20558.64 | 14899.83 | 17316.48 | 16783.64 | Upgrade |
Cash Interest Paid | 5,068 | 4,939 | 4,997 | 4,345 | 4,389 | 4,007 | Upgrade |
Cash Income Tax Paid | 32,254 | 28,544 | 7,765 | 4,236 | 5,412 | 5,001 | Upgrade |
Levered Free Cash Flow | 31,366 | 81,104 | 68,106 | -34,067 | 61,876 | 41,759 | Upgrade |
Unlevered Free Cash Flow | 34,594 | 84,354 | 71,233 | -31,347 | 64,484 | 44,311 | Upgrade |
Change in Net Working Capital | 12,501 | -19,391 | -1,158 | 9,275 | 4,925 | -3,108 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.